Back to today’s briefing

Story perspectives

Funding Cuts Threaten Hope in Pancreatic Cancer Research

5/3/2025

32 5

Summary

Story summary

Pancreatic cancer claims more lives than any other cancer, with a disheartening five-year survival rate of just 13%. Recent federal funding cuts jeopardize vital research and treatment options. Advocates urge for renewed investment, highlighting promising breakthroughs in targeting KRAS gene mutations that could pave the way for better outcomes and hope for patients.

1 of 1

Story summary

Pancreatic cancer claims more lives than any other cancer, with a disheartening five-year survival rate of just 13%. Recent federal funding cuts jeopardize vital research and treatment options. Advocates urge for renewed investment, highlighting promising breakthroughs in targeting KRAS gene mutations that could pave the way for better outcomes and hope for patients.